PCOS, Hormonal Imbalance, and Its Impact on Women’s Health

Introduction

PCOS, is an abbreviation for Polycystic Ovarian Syndrome. In Ayurveda, it is categorized as “Garbharoga”, a common disease of the Uterus.

According to Harvard Healthⁱ, “Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder where ovaries produce excess testosterone, causing irregular periods, infertility, acne, and excessive hair growth. Affecting 13% of women, it is driven by genetics and insulin resistance.”

PCOS is a complex endocrinal and metabolic condition. To understand it further from the Western medicine perspective, please read the Western Pathology section. Western pathology reviews this condition through various tests, discussed in the Tests section and addresses this condition through various treatments, discussed in the Treatment section.

Ayurvedic classification of PCOS is discussed per the Sushruta Samhita and Caraka Samhita. Ayurvedic pathology discuss the nidana (etiology), rupa (symptoms) and samprapti (pathology) while Ayurvedic management discuss the chikitsa (classical line of treatment and management of the disease).

Western Pathology

Introduction & Nomenclature – Polyendocrine Metabolic or Polycystic Ovarian Syndrome (PMOS / PCOS)

In Western medicine, Polycystic Ovary Syndrome (PCOS) is a heterogenous, complex neuroendocrine and metabolic disorder. Historically viewed as a localized gynecological problem, international updates have formally rebranded the condition as Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change highlights its systemic metabolic nature rather than the mere presence of benign ovarian structures. [1ⁱⁱ, 2ⁱⁱⁱ, 3^iv]

Pathogenesis & Pathophysiology

The pathology of PMOS involves a multifaceted vicious cycle driven by four main mechanisms:

Neuroendocrine Dysfunction: An abnormal increase in gonadotropin-releasing hormone (GnRH) pulse frequency triggers the pituitary gland to hyper secrete luteinizing hormone (LH) relative to follicle-stimulating hormone (FSH). [4^v, 5^vi]

Ovarian Hyperandrogenism: Elevated LH directly stimulates ovarian theca cells, overproducing male hormones like testosterone and androstenedione. [6^vii, 7^viii, 8^ix, 9^x, 10^xi]

Follicular Arrest: Excess local androgens impair normal folliculogenesis. This process halts follicle development before dominance, presenting as subcapsular antral follicles. [11^xii, 12^xiii, 13^xiv, 14^xv, 15^xvi]

Metabolic Insulin Resistance: Peripheral insulin resistance leads to compensatory hyperinsulinemia. Excess insulin acts synergistically with LH to stimulate ovarian androgen output and lowers sex hormone-binding globulin (SHBG), increasing free, bioactive testosterone. [16^xvii, 17^xviii, 18^xix, 19^xx, 20^xxi]

Diagnostic Criteria & Clinical Pathology

Diagnosis follows the updated Rotterdam Criteria^xxii, requiring at least two of the following components: [22^xxiii, 23^xxiv, 24^xxv, 25^xxvi]

Ovulatory Dysfunction: Exhibiting as oligomenorrhea (infrequent cycles) or amenorrhea (absent cycles). [26^xxvii]

Hyperandrogenism: Validated clinically by hirsutism and severe acne, or biochemically via elevated free and total testosterone. [27^xxviii, 28^xxix]

Polycystic Ovarian Morphology: Identified via ultrasound showing ≥20 follicles (2–9 mm) or an ovarian volume exceeding 10 mL. Recent guidelines approve elevated Anti-Müllerian Hormone (AMH) as a biochemical alternative to ultrasound. [29^xxx, 30^xxxi, 31xxxii, 32xxxiii]

Systemic Comorbidities & Long-Term Risks

Metabolic Syndrome: Up to 70% of patients experience significant insulin resistance, escalating the risk for Type 2 Diabetes Mellitus and cardiovascular diseases.

Oncological Risks: Chronic exposure to unopposed estrogen due to anovulation leads to continuous proliferation of the uterine lining, significantly boosting the risk for endometrial hyperplasia and carcinoma. [33^xxxiv, 34^xxxv, 35^xxxvi, 36^xxxvii, 37^xxxviii]

Tests

Discussed below are some of the blood test markers that are reviewed when addressing PCOS treatment. Listed below is a reference range for each marker taken from a Quest Diagnostics Lab Report^xxxix.

ESTRADIOL:

Reference Range

Female:
Follicular Phase: 30-144
Mid-Cycle: 64-357
Luteal Phase: 56-214
Postmenopausal: < or = 31

High levels of estradiol can occur from taking certain medications (estrogen replacement therapy) or dietary supplements. There are also some medical conditions associated with an overproduction of estrogen hormones and result in high estradiol levels. These conditions include obesity, polycystic ovarian syndrome (PCOS), liver disorders, and more. Be sure to consult with your doctor about any abnormal hormone levels and how your levels align with your health status and symptoms.

FSH and LH:

Reference Range

Follicular Phase 2.5-10.2
Mid-cycle Peak 3.1-17.7
Luteal Phase 1.5- 9.1
Postmenopausal 23.0-116.3
Luteinizing Hormone (LH) – The test for luteinizing hormone (LH), a hormone associated with reproduction and the stimulation of the release of an egg from the ovary (ovulation) in women and testosterone production in men, measures the level of LH in your blood or urine. Follicle-stimulating Hormone (FSH) – The test for follicle-stimulating hormone (FSH), a hormone associated with reproduction and the development of eggs in women and sperm in men, measures the level of FSH in your blood or urine.

T4, FREE:

Reference Range: 0.8-1.8 ng/dL

Thyroxine (T4) and triiodothyronine (T3) are the two major hormones produced by the thyroid gland. The majority of T4 is found in the body bound to proteins, with a smaller portion not bound to proteins, or “free.” Free (unbound) T4 is secreted by the thyroid gland as the biologically active form, which plays a role in controlling the rate of metabolism and growth. Most of the T4 secreted is converted to T3 by the liver and other tissues. Once converted, T3 plays a role in metabolic rate, ATP production, protein breakdown, and glucose transport in muscle cells.

TSH and FREE T4:

Reference Range

> or = 20 Years 0.40-4.50
Pregnancy Ranges
First trimester 0.26-2.66
Second trimester 0.55-2.73
Third trimester 0.43-2.91
The blood tests that are most widely used to evaluate thyroid function include those that measure TSH, T4, T3, free T4, and thyroid antibody levels. Read more about these tests in the brochure provided by the American Thyroid Association (ATA).

ANTI-MULLERIAN HORMONE (AMH), FEMALE:

Reference Range: 1.02-14.63 ng/mL

PROLACTIN:

Reference Range Females

Non-pregnant 3.0-30.0
Pregnant 10.0-209.0
Postmenopausal 2.0-20.0

Western Treatment

Management includes lifestyle changes, hormonal birth control, and addressing metabolic risks.

First-Line Pharmaceutical Interventions Report

Western medical management treats PMOS/PCOS based on the patient’s primary symptoms, metabolic profile, and current fertility goals.

1. Combined Oral Contraceptive Pills (COCPs)

COCPs are the first-line defense for patients who do not wish to become pregnant. They manage irregular cycles and signs of excess male hormones.

Mechanism of Action: The estrogen component increases Sex Hormone-Binding Globulin (SHBG) production in the liver. Higher SHBG binds free testosterone in the blood, making it inactive. The progestin component suppresses pituitary LH secretion, lowering ovarian testosterone production.

Clinical Effect: Regularizes withdrawal bleeding to prevent endometrial hyperplasia. It also effectively treats acne and slows unwanted hair growth.

Common Prescriptions: Ethinyl estradiol combined with a low-androgen or anti-androgen progestin (e.g., drospirenone or cyproterone acetate).

2. Insulin Sensitizers (Metformin)

Metformin is an oral biguanide medicine used first-line to address the underlying metabolic issues of the syndrome.

Mechanism of Action: It reduces the amount of glucose produced by the liver and increases insulin sensitivity in peripheral tissues like muscle.

Clinical Effect: By lowering insulin levels, it reduces the extra stimulation on ovarian theca cells. This reduces total testosterone levels, helps restore spontaneous ovulation, and aids in weight management.

Target Group: Patients with proven insulin resistance, pre-diabetes, or those who cannot take oral contraceptives.

3. Anti-Androgens (Spironolactone)

When oral contraceptives do not fully control symptoms of high male hormones after six months, doctors add anti-androgen therapy.

Mechanism of Action: Spironolactone works as a competitive androgen receptor antagonist. It blocks male hormones from binding to hair follicles and oil glands, and slows down the enzyme that creates testosterone.

Clinical Effect: Reduces severe cystic acne and slows down modified male-pattern hair growth (hirsutism).

Safety Note: Because it can cause birth defects in a male fetus, it must always be paired with reliable birth control.

4. Ovulation Induction Agents (Letrozole & Clomiphene)

For patients whose primary goal is fertility, managing the cycle focuses on forcing the ovaries to release an egg.

Letrozole (First-Line): An aromatase inhibitor that temporarily blocks estrogen production. The brain notices this drop and releases a surge of Follicle-Stimulating Hormone (FSH), stimulating the ovaries to mature and release a dominant egg.

Clomiphene Citrate (Alternative): A selective estrogen receptor modulator (SERM) that binds to receptors in the brain to trick the body into producing more FSH and LH.

Ayurvedic Classification

Introduction & Conceptualization

In Ayurveda, Polycystic Ovarian Syndrome (PCOS) is a type of Raktaja Gulma, tumors of the female reproductive system. PCOS does not have a single direct equivalent. Instead, it is understood as a complex manifestation involving multiple tissues (dhatus), biological energies (doshas), and metabolic fire (agni). It is primarily correlated with conditions like Artava Kshaya (deficient menstrual fluid), Nashtartava (loss of menstruation), and various Yonivyapad (gynecological disorders). [39^xl, 40^xli, 41^xlii, 42^xliii]

Sushruta Samhita and PCOS

The Sushruta Samhita does not explicitly name Polycystic Ovary Syndrome (PCOS), as it is a modern endocrine diagnosis. Instead, Ayurveda classifies it as an Anukta Vyadhi (unmentioned disease), but Acharya Sushruta details several conditions that perfectly mirror its clinical presentation. [43^xliv, 44^xlv]

Sushruta attributes these pathologies to a vitiation of Vata and Kapha doshas blocking the Artavavaha Srotas (the channels carrying menstrual fluid and ovum). [45^xlvi, 46^xlvii]

1. Artava Kshaya (Deficiency of Menstrual Fluid)

Sushruta defines Artava Kshaya as a condition where menstruation does not appear at the right time, is delayed, or is exceptionally scanty. This directly correlates to the oligomenorrhea (irregular, infrequent periods) seen in 87% of modern PCOS cases. He notes it causes vaginal pain and discomfort. [47^xlviii, 48^xlix, 49^l, 50^li]

2. Nashtartava (Loss of Menstruation)

When Vata and Kapha completely obstruct the reproductive channels, it leads to Nashtartava (destruction or absence of menses). This aligns with secondary amenorrhea, another hallmark feature where women with PCOS stop getting their periods entirely. [51^lii, 52^liii, 53^liv, 54^lv]

3. Yonivyapada (Uterine/Vaginal Disorders)

Among the female reproductive disorders (Yonivyapada), Sushruta highlights Vandhya Yonivyapada (infertility-related reproductive dysfunction). He notes that a blockage of Artava directly hinders a woman’s ability to conceive, mapping to PCOS-induced anovulatory subfertility. [55^lvi, 56^lvii]

4. Shatkriyakala (Pathology Progression)

In the Sutrasthana chapter of the Sushruta Samhita, Sushruta outlines the Shatkriyakala (six stages of disease pathogenesis). Modern Ayurvedic practitioners use this exact 6-step framework to track how toxins (Ama) and metabolic errors (Agni mandya) progress to form ovarian cysts and insulin resistance.

Caraka Samhita and PCOS

The Caraka Samhita does not explicitly mention Polycystic Ovary Syndrome (PCOS) by name, as it is considered an Anukta Vyadhi (an un-described or newly emerging disease). However, Ayurvedic physicians map its multifaceted symptoms to specific metabolic and gynecological principles outlined by Acharya Caraka: [57^lviii, 58^lix, 59^lx, 60^lxi, 61^lxii]

Santarpanottha Vyadhi (Over-nutrition/Metabolic Diseases): Caraka categorizes disorders stemming from excessive nourishment, sedentary habits, and metabolic sluggishness under this umbrella. This directly aligns with the insulin resistance and obesity seen in PCOS. [62^lxiii, 63^lxiv, 64^lxv]

Tridosha & Agni Imbalance: The text describes how a weakened digestive and metabolic fire (Agnimandhya) leads to the accumulation of metabolic toxins (Ama). This causes a Kapha-Vata predominant imbalance where aggravated Kapha blocks the bodily channels (Margavarana), obstructing normal hormonal and menstrual flow managed by Vata. [65lxvi, 66lxvii, 67lxviii, 68lxix, 69lxx]

Yonivyapad (Gynecological Disorders): While Caraka details 20 types of Yonivyapad (uterine and reproductive ailments), PCOS symptoms are cross-referenced with conditions like Artava Dushti (vitiated menstrual fluid/ovum) and Nashtaartava (loss or scanty flow of menses). [70^lxxi, 71^lxxii, 72^lxxiii, 73^lxxiv, 74^lxxv]

Three Diagnostic Principles: To decode modern diseases like PCOS, the Caraka Samhita advises evaluating three factors: the site of manifestation (Adhisthana), the specific causative factors (Samutthana-vishesha), and the unique nature of the symptoms (Vikaraprakriti). [75^lxxvi, 76^lxxvii, 77^lxxviii]

Ayurvedic Pathology

Nidana (Etiology)

In Ayurveda, Nidana translates to etiology or cause of the disease. Per the Clinical Ayurvedic Medicine textbook for the Ayurvedic Medicine by Dr. Marc Halpern^lxxix, “Polycystic ovarian cysts are primarily due to a Vata imbalance. This pushes Pitta and Kapha out of balance. It is a sannipatika condition in the Shukravaha srotas. Vata is vitiated due to irregular habits and lifestyle, eating an excess of cold, light and dry foods and foods that have bitter, pungent and astringent tastes. Another nidana is anxiety, which is due to the Vata vitiation.”

Rupa (Symptoms)

In Ayurveda, Rupa translates to signs and symptoms of the disease. Per the Clinical Ayurvedic Medicine textbook for the Ayurvedic Medicine by Dr. Marc Halpern, “Symptoms for PCOS can vary from woman to woman. Here are some of the typical symptoms associated with PCOS.

Acne
Menstrual irregularities or Amenorrhea
Hirsutism or virilization means more masculine characteristics like body and facial hair
Decreased breast size
Infertility
Diabetes with insulin resistance
Weight gain and obesity
Acanthosis means if there are thick, dark skin around the folds of the neck, arms, thighs or breasts.

Other complications include high blood pressure, cardiovascular disease, diabetes, and fatty liver.”

Samprapti (Pathology)

Ayurvedic pathology is called Samprapti, which represents the complete pathogenesis and progression of a disease. It details how an imbalance starts, spreads, and manifests as symptoms

The Ayurvedic perspective focuses on the blockage of bodily channels (Srotorodha) caused by the accumulation of metabolic toxins (Ama). This stagnation disrupts the flow of communication and nourishment within the reproductive system: [79^lxxx]

Vata Dosha (Apana Vayu): Responsible for downward movement and the regular shedding of the endometrium and release of the ovum. Its vitiation or obstruction leads to irregular cycles and anovulation. [80^lxxxi, 81^lxxxii, 82^lxxxiii]
Kapha Dosha: Represents stability, fluid, and tissue growth. Excess Kapha leads to tissue accumulation, manifesting as structural changes like ovarian cysts and weight gain. [83lxxxiv]
Pitta Dosha: Governs hormonal transformation. When mixed with vitiated Kapha, it triggers inflammatory and metabolic disturbances such as insulin resistance and acne. [84lxxxv]
Dhatu Involvement: The pathology primarily compromises Rasa (plasma), Rakta (blood), Mamsa (muscle), Meda (fat), and ultimately Shukra/Artava (reproductive tissue). [85lxxxvi]

Ayurvedic Management

Chikitsa (Classical Line of Treatment and Management)

Clinical trials and reviews, such as those analyzed by the All India Institute of Ayurveda^lxxxvii or indexed on PubMed^lxxxviii, validate a structured, multi-pronged treatment regimen: [88^lxxxix, 89^xc, 90xci]

1. Purification (Shodhana / Panchakarma)

Deep cellular detoxification is employed to eradicate Ama and clear channel blockages (Srotorodha). [91^xcii]

Vamana (Therapeutic Emesis): Indicated for dominant Kapha to clear heavy, stagnant humors.

Virechana (Therapeutic Purgation): Eliminates excess Pitta, clearing toxins from the blood and liver.

Basti (Medicated Enemas): The premier treatment for correcting Apana Vayu imbalance, delivering therapeutic oils or herbal decoctions to balance the reproductive axis. [92^xciii]

2. Oral Herbal Management (Shamana)

Herbal formulations focus on balancing hormones, improving insulin sensitivity, and reducing cyst size: [93^xciv, 94^xcv]

Kanchanar Guggulu & Varunadi Kwath: Celebrated for clearing benign tissue growths and fluid cysts.
Shatavari (Asparagus racemosus): Supports ovarian follicle development and addresses subfertility.
Ashwagandha (Withania somnifera): Regulates the hypothalamic-pituitary-ovarian (HPO) axis by lowering cortisol and combating stress-induced hormonal imbalances.
Guduchi (Tinospora cordifolia) & Turmeric (Curcuma longa): Utilized for their proven anti-inflammatory properties and ability to regulate glucose metabolism. [95^xcvi, 96^xcvii, 97xcviii, 98xcix, 99c, 100ci]

3. Diet and Lifestyle (Ahara & Vihara)

As noted in clinical reviews published by ScienceDirect^cii, lifestyle modifications form the baseline of long-term metabolic correction: [102^ciii]

Dietary Adjustments: Focus on fresh, warm, well-cooked whole foods while strictly avoiding refined sugars, white flour, and heavily processed items. [103^civ]

Therapeutic Exercise: Implementing specific yoga asanas (like Paschimottanasana and Bhadrasana) alongside pranayama helps improve circulation to the pelvic area and reduce weight. [104^cv, 105^cvi]

Panchakarma Expansion: Basti Chikitsa (Medicated Enema Therapy)

In Ayurvedic pathology (Samprapti), the root cause of ovulatory failure and menstrual irregularity is the vitiation of Apana Vayu—the sub-dosha of Vata residing in the pelvic cavity that governs elimination, menstruation, and ovulation. Basti (Medicated Enema) is clinically considered the premier treatment for PCOS because it directly targets the colon, the primary seat of Vata, while simultaneously cleansing the metabolic channels (Srotas). [106^cvii, 107^cviii, 108^cix, 109^cx]

For PCOS management, Ayurvedic clinicians typically employ a specialized, alternating schedule of two types of Basti: [110^cxi]

Matra Basti (Nutritive Oil Enema): Uses unctuous, warm medicated oils like Sahacharadi Taila or Dhanwantaram Taila. It pacifies the dryness and hyperactivity of Vata, nourishes the reproductive organs, and softens tissue stagnation. [111^cxii, 112^cxiii, 113^cxiv, 114^cxv, 115^cxvi]

Kashaya Basti (Cleansing Decoction Enema): Uses complex herbal decoctions blended with honey, rock salt, herbal pastes (Kalka), and tailored oils. This combination acts as a scraping agent (Lekhana) to clear accumulated Kapha, dissolve cysts, and eradicate metabolic toxins (Ama). [116^cxvii, 117^cxviii, 118^cxix]

By normalizing the downward movement of Apana Vayu, Basti restores communication along the hypothalamic-pituitary-ovarian (HPO) axis, paving the way for regular, spontaneous follicular rupture. [119^cxx]

In holistic and alternative philosophies, the spiritual root of PCOS (Polycystic Ovary Syndrome) is often linked to a blocked or imbalanced Swadhisthana (sacral) chakra. Located in the lower abdomen, this energy center governs your creative force, emotions, sexuality, and feminine life energy.

The Mind-Body Connection

Repressed Creativity & Femininity: Many spiritual practitioners suggest that PCOS symbolizes a blockage in manifesting your “inner creations.” This might manifest as feeling disconnected from your divine feminine energy, suppressing your passions, or a fear of stepping into your full creative power.

Holding Onto the Past: Ovarian cysts are metaphorically viewed as unexpressed emotions, past traumas, or unresolved grief that the body is physically “holding on to” rather than releasing.

Protection vs. Vulnerability: The hardening of the ovaries and the physical traits associated with PCOS are sometimes interpreted as the body building a “shield” against emotional pain or past hurt. It represents an internal boundary that prevents vulnerability.

Spiritual and Holistic Healing

To address these perceived spiritual roots, many turn to holistic and mindfulness practices:

Chakra Balancing: Practices focusing on unblocking the sacral chakra include yoga, wearing or meditating with the color orange, and water-based therapies.

Emotional Release: Techniques like journaling, trauma therapy, and forgiveness exercises are used to release unresolved grief and fear, allowing energy to flow freely in the reproductive area.

Embracing Feminine Energy: Activities that foster self-love, sensual pleasure, and connection to your body’s innate rhythms are often recommended to restore energetic harmony.

Note: While spiritual and emotional work can provide profound peace and holistic wellbeing, PCOS is a complex endocrinal and metabolic condition. It is highly recommended to combine spiritual practices with conventional medical guidance to properly manage symptoms like insulin resistance and hormone imbalances.

Conclusion

Ayurvedic interventions approach PCOS as a systemic metabolic and reproductive dysfunction rather than localized ovarian disease. By combining detoxification, targeted herbal therapeutics, and personalized lifestyle corrections, it addresses the root cause to restore ovulatory regularity and metabolic health. [120^cxxi]